Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Differentiating primary human cells in rapid-throughput discovery applications.

Marshak DR., Greenwalt DE.

Laboratory Study, published in Methods Mol Biol (2007) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Methods Mol Biol (2007)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
16988399
DOI
10.1385/1-59745-217-3:121

Abstract (original English)

Primary cultures of human cells provide an increasingly important alternative to using virally transformed or otherwise immortalized cell lines or to using cloned cell lines derived from human or animal tumors. Advances in primary cell culture techniques, media formulations, and other reagents have enabled routine culture of primary cells derived from human tissues for biomedical research and drug discovery approaches such as high content screening. That primary cells retain the phenotypic characteristics of the original tissue is one main advantage over immortalized cell lines. However, securing reliable supplies of primary cells on a large scale has been problematic. Here, two primary differentiating cell types, preadipocytes and preosteoclasts, are described to illustrate the utility of commercially produced cell systems in discovery research and rapid-throughput applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesBiomedical ResearchCell DifferentiationCells, CulturedCollagenHumansOsteoclastsStem CellsTriglycerides

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.